Invivyd IVVD
NASDAQ IVVD
$0.60 +0.02 (+4.01%)
As of: Nov 11, 2026 · 3:59 PM EST

Invivyd (IVVD) Long-Term Deferred Tax (2023 - 2025)

Updated

Analysis

Invivyd (IVVD) Long-Term Deferred Tax (2023 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Invivyd 168.01 Mn -487.88 Mn 13.01 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 252.95 Mn
Dec 31, 2024 244.95 Mn
Dec 31, 2023 2.73 Mn
API Access

Invivyd Long-Term Deferred Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=IVVD&period=max&api_key=YOUR_API_KEY